Naveris
PrivateLast Round
Series B
Jun 17, 2024
Est. Valuation
$81.49M
Total Funding Raised
$69.9M
Momentum Score
25 /100
Company Overview
Naveris is a biotechnology company that specializes in blood test technology for the early detection of specific cancer subtypes and enhancing patient outcomes through real-time monitoring and recurrence detection.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Naveris Comps
Public and private peers based on sector, stage, and business model.
Naveris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 17, 2024 | ||||
| Series A Extension | Sep 19, 2022 | ||||
| Series A | Dec 15, 2020 |
Key People
Founding team and executive leadership
Naveris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BrightEdge | Series A Extension |
| BrightEdge | Series A Extension |
| Gurnet Point Capital | Series B, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Flagship test trusted by thousands of physicians and institutions.
- Mar 1, 2026
Active integration with the healthcare data platform Redox.
Naveris Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Naveris's valuation, stock price, and market status.
